Molecular subtyping drives confident treatment decisions for breast cancer

Human Breast Cancer Molecular Subtyping Quantitative Detection Kit(PCR-Fluorophore-labeling Probes)

China NMPA certified | CE Certified

learn more

Non-invasive, Instant, Home-based and Self-testing

Prediction and Screening of Pre-eclampsia in the 2nd and 3rd Trimester of Prenancy.

China NMPA certified | CE Certified

learn more

Syphilis TP and nTP antibodies dual tests

One-Step Dual Antibody Detection for Syphilis Screening & Active Infection Diagnosis

CE Certified

learn more

Latest News

Shuwen Biotech Announces PRE-CERCA International Study Evaluating CercaTest RED™ for Prediction of Preeclampsia

DEQING, CHINA, August 17, 2026 /EINPresswire.com/ — Shuwen Biotech today announced the initiation of the PRE-CERCA study (PREdicting Preeclampsia using CercaTest® RED Urine Test), an international multicenter clinical study evaluating whether CercaTest RED™, a next-generation point-of-care urine test, can accurately predict preeclampsia in women presenting with suspected preeclampsia. The study is co-led […]
Read more

Shuwen Biotech Announces South African Clinical Study of CercaTest RED™ for Short-Term Prediction of Preeclampsia

DEQING, CHINA, July 21, 2026 /EINPresswire.com/ — Shuwen Biotech today announced the initiation of a prospective clinical study by leading experts in South Africa evaluating CercaTest RED™, its novel point-of-care urine test for misfolded proteins, for the short-term prediction of preeclampsia in women at high risk presenting with suspected […]
Read more

Cerca Biotech Releases New White Paper on Ki-67 Testing in Breast Cancer

MammaTyper® Establishes Benchmark Reproducibility & Reliability for Ki-67 and Core Breast Cancer Biomarkers BERLIN, GERMANY, July 16, 2026 /EINPresswire.com/ — Cerca Biotech has officially published a dedicated White Paper focused on Ki-67 detection, demonstrating the superior performance in reproducibility and analytical reliability of MammaTyper® for Ki-67 alongside other key breast cancer biomarkers […]
Read more
read more

Screening, diagnosis & precision medicine for women’s health.

We are committed to becoming a global leader in innovative diagnosis and precision medicine focused on women’s health.

Precision Medicine for Breast Cancer

Precision Medicine for Oncology

Maternal Fetal Diagnostics & Health

Reproductive Tract Infection & Health
R&D Center
Diagnostics for Maternal Fetal Medicine
Marketing and Sales
IVD Products Manufacturing
Central Laboratory Services
Production and Marketing Center for Global Market

Every women deserves better diagnosis and precision medicine

Precision diagnostic products or services covering breast health, maternal fetal medicine, reproductive tract infections, tumor detection, and family health management.
learn more